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ABSTRACT
Nineteen primiparous cows were experimentally in-
fected in 2 quarters with 1 × 104 (group A) or 1 × 106
(group B) cfu of Escherichia coli P4:O32 per quarter
within 2 to 4 wk after parturition. Blood and milk sam-
ples were collected from all primiparous cows at regular
time intervals from d −4 to d +3 relative to inoculation.
Milk production rapidly decreased in both groups dur-
ingE. colimastitis, but recovery appeared to be faster in
group B at d + 1 postinfusion (p.i.). The milk production
losses in the noninfected quarters were substantial on
the day of inoculation, which is probably due to pro-
nounced systemic effects. However, on d + 2 p.i. milk
production in the noninfected quarters nearly reached
preinfection levels, indicating amoderate clinical sever-
ity following intramammary inoculation. None of the
other severity criteria evolved towards a severe re-
sponse pattern. Reticulorumen motility was inhibited
in both groups during E. coli mastitis. The clinical epi-
sode was short lasting in both groups. Rectal tempera-
ture, heart rate, blood leukocyte count, number of col-
ony-forming units, milk somatic cell count and several
indicators for the disintegration of the blood-milk bar-
rier returned to normal values within 24 to 72 h p.i.
Primiparous cows reacted with a moderate inflamma-
tory response following intramammary infusion with a
relatively high dose of E. coli. Despite the use of a
high inoculum dose, primiparous cows in both groups
showed pronounced resistance against severe intra-
mammary E. coli infection. A possible effect of the ino-
culum dose could be present, however, further research
into the effect of the inoculum dose on the inflammatory
response should be performed.
(Key words: primiparous dairy cow, Escherichia coli
mastitis, inoculum size, early lactation)
Abbreviationkey:BLC=blood leukocyte count,HR=
heart rate, MP = milk production, PCV = packed cell
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volume, p.i. = postinfusion, PIH = postinfusion hour,
QMP = quarter milk production, ROS = reactive oxy-
gen species, RR = respiration rate, RT = rectal tem-
perature.
INTRODUCTION
Several factors have been shown to play a role in
the clinical outcome of Escherichia coli mastitis,
namely farm management (Smith et al., 1985; Schuk-
ken et al., 1989a, 1989b; Oliver et al., 1990; Lam et
al., 1995; Barkema et al., 1999), bacterial factors (Frost
et al., 1980; Hill, 1981; Linton and Robinson, 1984;
Sanchez-Carlo et al., 1984a; Sanchez-Carlo et al.,
1984b; Todhunter et al., 1991; Hogan et al., 1992;
Cross et al., 1993; Nemeth et al., 1994; Hogan et al.,
1995, 1999; Nagy and Fekete, 1999), and physiological
factors (Heyneman et al., 1990; Gilbert et al., 1993;
Kremer et al., 1993a, 1993b; Vandeputte-Van Messom
et al., 1993; Dosogne et al., 1997, 2001; van Werven
et al., 1997; Mehrzad et al., 2001, 2002; Vangroen-
weghe et al., 2001; Burton and Erskine, 2003).
Preventive measures, which are known to be effi-
cient against contagious mastitis, such as postmilking
teat disinfection (Schukken et al., 1989a, 1989b; Bar-
kema et al., 1999) have been shown to be inefficient
in the control of E. coli mastitis (Smith et al., 1985;
Oliver et al., 1990; Lam et al., 1995). Several epidemio-
logical studies have demonstrated a negative correla-
tion between SCC and the incidence of E. colimastitis.
Therefore, SCC is thought to be a farm-related risk
factor for the susceptibility to E. coli mastitis (Schuk-
ken et al., 1989a, 1989b; Barkema et al., 1999).
Various bacterial virulence factors have been stud-
ied duringE. colimastitis (Sanchez-Carlo et al., 1984a,
1984b); however, only a few have been found to sub-
stantially influence the eventual outcome of the dis-
ease.Escherichia coli is of environmental origin (Nem-
eth et al., 1994). Although over 100 subtypes have been
recognized, no specific O-serotypes have been related
to bovine E. colimastitis (Linton and Robinson, 1984).
Nevertheless, intramammary challenge with E. coli
487 caused more severe clinical signs of mastitis than
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did E. coli 727 (Hogan et al., 1992, 1995, 1999; Tod-
hunter et al., 1991). Moreover, a capsulated E. coli
B117 strain appeared to cause more severe clinical
symptoms of mastitis because it was more difficult to
opsonize than a noncapsulated E. coli P4 strain (Hill,
1981). Clinical expression after challenge with low
doses of E. coli is comparable with those after inocula-
tion of high doses (Frost et al., 1980). The adhesion
factors present in enterotoxigenic E. coli, which are
essential during the initial steps of adhesion in patho-
genesis, do not play a role in the pathogenesis of E. coli
mastitis (Nagy and Fekete, 1999). A bacterial factor,
which plays an important role in the pathogenesis of
E. coli mastitis, is endotoxin or LPS. Lipopolysaccha-
ride is a potent inducer of inflammatory cytokines
(Shuster et al., 1993) during growth and killing (Bur-
venich, 1983). Clinical signs following experimentally
induced E. coli mastitis are due to mediator shock
rather than to endotoxin shock, because endotoxin
mainly plays a local role (Hoeben et al., 2000; Dosogne
et al., 2002).
Physiological factors have a big impact on the clini-
cal outcome of E. colimastitis (Burvenich et al., 2003),
far more than farmmanagement and bacterial charac-
teristics that were sited above. Several markers to
predict the clinical outcome of E. coli mastitis have
been studied, such as the number of circulating leuko-
cytes, production of reactive oxygen species (ROS) by
neutrophils (Heyneman et al., 1990; Vandeputte-Van
Messom et al., 1993), and chemotactic activity of PMN
(Kremer et al., 1993a; Kremer et al., 1993b; Dosogne
et al., 1997; vanWerven et al., 1997). However, predict-
ability of clinical outcome is only significant during 1
to 2 d prechallenge and does not explain any causal
relationship. These markers were mainly studied in
multiparous cows, varying between second lactation
(Heyneman et al., 1990; Vandeputte-Van Messom et
al., 1993; Dosogne et al., 1997) to second to sixth lacta-
tion (Kremer et al., 1993a, 1993b; van Werven et al.,
1997). Because BHBA alters both PMN chemotactic
activity and ROS production (Heyneman et al., 1990;
Kremer et al., 1993a, 1993b; Vandeputte-Van Messom
et al., 1993), many E. coli challenges that were exe-
cuted at Ghent University and the University of
Utrecht were performed on cows with a serum BHBA
concentration <1.4 mmol/L (Kremer et al., 1993b).
Early lactating cows, infected with E. coli, are much
more severely affected than cows after peak lactation
(Hill, 1981). This is mainly due to the impairment of
early lactation leukocyte function, as observed by
many research groups (Burton and Erskine, 2003).
During this period a decrease in cell function of the
PMN, resident in the healthy mammary gland (Do-
sogne et al., 2001; Mehrzad et al., 2001; Vangroen-
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weghe et al., 2001) has been observed. The decrease
in cell function was mainly related to the decrease in
viability, oxidative burst, and intracellular killing by
PMN (Dosogne et al., 2001; Mehrzad et al., 2001; Van-
groenweghe et al., 2001).
Besides energy balance and stage of lactation, cow
parity was also found to be an important physiological
factor that influences severity of clinical mastitis (Gil-
bert et al., 1993; van Werven et al., 1997; Mehrzad et
al., 2002). Blood PMN function was higher in younger
animals than in cows after their fourth parturition
(Gilbert et al., 1993; van Werven et al., 1997). More-
over, viability and oxidative burst have been found to
be significantly different between primiparous cows
and multiparous cows during the periparturient pe-
riod (Mehrzad et al., 2002).
In conclusion,many studies indicate that physiologi-
cal factors determine the clinical outcome of E. coli
mastitis. In this study the clinical outcome of E. coli
mastitis was studied in primiparous cows using the
same criteria for severity as in other studies using
multiparous cows (Heyneman et al., 1990; Vande-
putte-Van Messom et al., 1993; Dosogne et al., 1997;
van Werven et al., 1997; Hoeben et al., 2000).
The purpose of the present study was to evaluate
the outcome of intramammary E. coli inoculation in
primiparous cows under identical conditions as de-
scribed before with multiparous cows (Heyneman et
al., 1990; Vandeputte-Van Messom et al., 1993; Do-
sogne et al., 1997, 2002; Hoeben et al., 2000). More-
over, the relation between preinfection parameters
and the outcome of infection in term of severity was
assessed. Finally, 2 high-inoculum doses, with a 100-
fold difference (1 × 104 and 1 × 106 cfu), were used
because the amount of LPS produced is related to the
number of E. coli bacteria (Burvenich, 1983; Cross et
al., 1993; Monfardini et al., 1999). The primiparous
cows in this study were inoculated with the same
strain as described before (Vandeputte-Van Messom
et al., 1993; Hoeben et al., 2000; Dosogne et al., 2002).
MATERIALS AND METHODS
Experimental Animals and Study Facilities
All primiparous cows (n = 19) were in their seventh
month of pregnancy on arrival at the dairy farm
(CDFO—Commercial Dairy Farm Oudenaarde, Oude-
naarde, Belgium) and between 24 and 30 mo of age at
calving. The primiparous cows were on a system of
zero grazing from arrival until the end of the inocula-
tion trial and were fed twice daily at 0700 and 1700
h. The ration consisted of corn silage, good quality
hay, and water ad libitum. Concentrates (Sandilac;
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Dumoulin Voeders Sanders,Moorslede, Belgium)were
distributed according to milk production.
For inclusion into the intramammary inoculation
trial, treatment of clinical diseases (retentio secundin-
arum, mastitis, metritis, and so on) was not allowed
within 10 d before the intramammary inoculation.
Therefore, only healthy animals, free of major mastitis
pathogens through 3 consecutive bacteriologically neg-
ative examinations with a foremilk SCC below 200,000
cells/mL at quarter level, were included for the intra-
mammary E. coli challenge. Primiparous cows ac-
cepted for the intramammary challenge were inocu-
lated between 14 and 28 d postparturition.
Machine milking was performed daily at 0800 and
1800 h using a quarter milking device (Packo & Full-
wood, Zedelgem, Belgium). Daily quarter milk produc-
tion (QMP), the yield of the evening and subsequent
morningmilking, expressed as liters per day, wasmea-
sured at d −4, d −1, d 0 (postinfusion hour [PIH] 0 to
24), d1 (PIH 24 to 48), d 2 (PIH 48 to 72) and d 3 (PIH
72 to 96).
Inoculation Dose
The generation time of E. coli in mammary secre-
tions can be as short as 20min (Burvenich et al., 2003).
Therefore, 2 high inoculum doses (1 × 104 [group A;
n = 9] and 1 × 106 [groupB; n = 10] cfu) were used in this
experiment because we were interested in bacterial
clearance rather than in bacterial growth in the af-
fected mammary glands.
Intramammary Inoculation Procedure
and Experimental Design
Inoculation was performed as described before
(Hoeben et al., 2000). Briefly, E. coli P4:O32 (H37, β-
glucuronidase +, haemolysin −), maintained as a stock
in lyophilization medium at −20°C, was subcultured
in brain-heart infusion broth (CM225; Oxoid, Nepean,
ON, Canada) at 37°C during 3 consecutive days, subse-
quently washed 3 times with pyrogen-free PBS, and
resuspended in PBS. Just before inoculation, the sus-
pension was diluted in pyrogen-free PBS to a final
concentration of 1 × 104 cfu/mL (group A) or 1 × 106
cfu/mL (groupB). On d 0, 30min aftermorningmilking
(1.5 h after feeding), the cows were inoculated in the
left front and rear quarters with a total volume of 10
mL of pyrogen-free saline solution (0.9%) per quarter.
Animals were challenged on 4 different trial days.
The 1 × 104 cfu inoculum group (group A) was chal-
lenged in a group of 4 and 5 animals, and the 1 ×
106 cfu inoculum group (group B) was challenged in 2
groups of 5 animals.
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Table1.Severity estimation scheme, based on systemic disease signs,
for the classification of primiparous cows, following an experimental
inoculation with Escherichia coli P4:O32 (according to Wenz et al.,
2001; with slight modifications). Briefly, the 4 parameters are scored,
total score is calculated, and compared with respective ranges for
classification into mild, moderate, or severe disease. In the present
study, the total score did not exceed 5, meaning that no severe re-
sponses were observed throughout the entire experimental study
period.
Variable Criteria Score
Rectal temperature (°C) 37.80–39.25 0
39.30–39.80 1
>39.80 or <37.80 2
Skin turgor Regains normal shape in <5 s 0
Regains normal shape in >5 s 1
Rumen motility rate 3×/2 min 0
(contractions/min) 1-2×/2 min 1
0×/2 min 2
General attitude Alert 0
(signs of depression) Lethargic 1
Depressed-unable to stand 2
Extremely sick-recumbent 3
Total score Mild disease 0-2
Moderate disease 3-5
Severe disease 6-8
Sampling Procedure
Blood and milk samples were collected at d −4, d −1,
d 0, d +1, d +2 and d +3 relative to the day of challenge.
On the day of challenge, blood and milk samples were
collected at PIH 3, 6, 9, 12, 15, 18, and 21.
Blood samples were drawn aseptically from the ex-
ternal jugular vein of each cow by venipuncture in
evacuated tubes (lithium heparin for plasma prepara-
tion, sodium-fluoride for glucose analysis, and coagu-
lated for serum preparation) for subsequent use in
different analyses. Foremilk was aseptically collected
for diagnostic bacteriology on major pathogens before
inoculation and for quantification of the number of E.
coli (cfu) from PIH 3 onwards, determination of SCC,
and preparation of skim milk. All samples were kept
onmelting ice (1°C) during transport and at the labora-
tory until analysis was performed.
Clinical Examination
Classical clinical parameters were examined. Rectal
temperature (RT), heart rate (HR), respiration rate
(RR), rumen motility, skin turgor, fecal appearance,
appetite, general attitude, BCS (Edmondson et al.,
1989), and aspects of the mammary gland (abnormal
milk, swelling, teat relaxation, andmilk leakage [Mas-
sart-Lee¨n et al., 1988]) were recorded by a veterinarian
each time blood and milk samples were collected.
Severity Determination
The severity of E. coli mastitis was determined
based on QMP in the noninfected quarters at d +2
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Table 2. Preinfection levels of blood and milk constituents (expressed as means ± SEM) in primiparous
cows infused with 1 × 104 (group A; n = 9) and 1 × 106 (group B; n = 10) cfu of Escherichia coli P4:O32.
(Values are means ± SEM)
Group A Group B
(n = 9) (n = 10)
Blood constituents
β-Hydroxybutyric acid (mmol/L) 0.89 ± 0.20 0.66 ± 0.05
Glucose (mmol/L) 3.8 ± 0.3 3.2 ± 0.2
Blood leukocyte count (log10/mL) 6.942 ± 0.024 6.903 ± 0.027
Milk constituents
SCC (log10/mL) 4.46 ± 0.10 4.18 ± 0.07
Albumin (mg/dL) 23.4 ± 3.3 27.8 ± 3.1
Milk production (l/24 h per quarter) 3.4 ± 0.4 3.8 ± 0.2
Fat (g/24 h per quarter) 155 ± 22 164 ± 29
Protein (g/24 h per quarter) 101 ± 5 110 ± 8
Lactose (g/24 h per quarter) 169 ± 18 186 ± 12
postinfusion (p.i.). Animals with a QMP in the nonin-
fected quarters at d +2 higher than 50% compared
with their QMP at d −1 in the same quarters were
scored as moderate responders, whereas animals with
a QMP at d +2 lower than 50% were considered severe
responders (Vandeputte-Van Messom et al., 1993; Do-
sogne et al., 1997, 1999).Moreover, severitywas scored
based on Wenz et al. (2001) with some slight modifica-
tions. Therefore, clinical data (RT, skin turgor, reticu-
lorumen motility, and general attitude) obtained from
PIH 9 to 48 were scored as described in Table 1, and
based on their total score, primiparous cows were clas-
sified into mild, moderate, and severe responders.
SCC and Milk Composition
Somatic cell count was determined using a fluoro-
opto electronic method (Fossomatic 400 cell counter;
Foss Electrics, Hillerød, Denmark). Fat, protein, and
lactose concentration (g/L) were determined using
mid-infrared-photospectrometry (Foss Electrics). The
daily production of fat, protein, and lactose (g/24 h
per quarter) was calculated based on daily QMP and
concentration of these parameters.
Indicators of the Disintegration
of the Blood-Milk Barrier
Milk samples for the determination of serum albu-
min (mg/dL), sodium (Na+), chloride (Cl−), and po-
tassium (K+) concentration (mmol/L) were centrifuged
at 1000 × g (30 min, 4°C). Fat was removed and sam-
ples of skim milk were taken and immediately frozen
at −80°C until analysis. After thawing, serum albumin
was quantified using a radial immunodiffusion kit (bo-
vine low level albumin, Bethyl VET-RID; Bethyl Labo-
ratories,Montgomery, TX). Ion concentrationwas ana-
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lyzed using an ion-selective electrode analyzer (Ilyte;
Instrumentation Laboratories, Milan, Italy).
Packed Cell Volume, Blood Leukocyte
Count, and Differentiation
Blood packed cell volume (PCV) (%) was determined
in hematocrit-capillaries (60 µL/75 mm; Hirschmann
Laborgera¨te, Eberstadt, Germany) using a micro-he-
matocrit centrifuge (Hawksley, London, UK). Blood
leukocyte count (BLC) (log10/mL) was determined us-
ing an electronic particle counter (Coulter Counter Z2;
Coulter Electronics Ltd., Luton, UK). Differential BLC
was performed on blood smears. Briefly, 10 µL of ho-
mogenized whole blood was added onto a microscope
slide and very thin smears were prepared, following
drying and staining as described previously, differen-
tial counts were carried out (Mehrzad et al., 2001).
Colony-Forming United in the Inoculated Quarters
The number of E. coli (cfu/mL) after experimental
inoculation was determined by appropriate 10-fold di-
lutions of each milk sample in PBS. Ten microliters
of these dilutions was plated out on Columbia Sheep
Blood agar (Biokar Diagnostics, Beauvois, France). All
dilutions were performed in duplicate. Colonies were
counted after a 24-h incubation at 37°C. The colony
count was converted to cfu/mL based on the factor of
dilution and finally expressed as log10/mL for statisti-
cal analysis.
Glucose and β-Hydroxybutyrate in Serum
On arrival at the laboratory, clotted blood was incu-
bated for 2 h at 37°C to neutralize the cryoglobulins
present in bovine serum. After centrifugation (1000 ×
g, 20 min, 20°C), serum was aliquoted and stored at
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Table 3. Relationship between preinfection blood and milk constit-
uents and the reduction in MP at d +2 (postinfusion h 48 to72) in the
noninfected quarters of primiparous cows from both groups, assessed
by linear regression with correction for inoculum dose. The slope value
indicates the change in milk production reduction for one unit change
in the blood and milk constituents.
Standard
Slope error P-value
Blood constituents
β-hydroxybutyric acid (mmol/L) −24 14 0.110
Glucose (mmol/L) −11 6 0.089
Blood leukocyte count (log10/mL) −44 64 0.497
Milk constituents
SCC (log10/mL) +12 20 0.529
Albumin (mg/mL) −0.8 0.5 0.126
Milk production (l/24 h per quarter) +0.013 0.014 0.120
Fat (g/24 h per quarter) +0.14 0.07 0.060
Protein (g/24h per quarter) +0.37 0.20 0.089
Lactose (g/24 h per quarter) +0.23 0.12 0.067
−80°Cuntil analysis of BHBA.NaF-collected bloodwas
centrifuged (1000 × g, 20 min, 20°C) and plasma was
collected and stored at −20°C until analysis of glucose.
Glucose concentration (mmol D-glucose/L) was de-
termined using an UV-method (D-Glucose; Roche Di-
agnostics, Brussels, Belgium). β-Hydroxybutyrate
(mmol/L) was determined twice in the week before
challenge to check the status of the cow’s energy bal-
ance. For analysis, the method with acetone oxidation,
described by Williamson and Mellanby (1970), was
used.
Statistical Analysis
The 2 inoculum groups were not formally compared
because inoculum dose was not randomly assigned to
animals. Preinfection values of blood and milk constit-
uents of the inoculum groups (Table 2) were compared
just before intramammary E. coli inoculation using
a paired 2-sided t-test, assuming unequal variances
(Statistix; Analytical Software, Tallahassee, FL). The
relationship between preinfection concentrations of
blood and milk constituents and the milk production
reduction in the noninfected quarters at d +2 (PIH
48 to 72) was assessed by linear regression with an
adjustment for inoculum size.
RESULTS
Relation Between Preinfection Blood and Milk
Constituents and Percentage Reduction
in MP at d +2 p.i.
No significant relationships between preinfection
blood and milk constituents and the reduction in MP
at d +2 p.i. could be demonstrated (Table 3).
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Figure 1. Milk production (L/d) of the uninfected right quarters
fromd −4until d +3 relative to infusion fromprimiparous cows infused
with 1 × 104 (—; group A; n = 9) and 1 × 106 (------; group B; n = 10)
cfu of Escherichia coli P4:O32. Data are means (± SEM).
Clinical and Laboratory Results of Primiparous
Cows in Group A Inoculated with 1 × 104 cfu
All primiparous cows in group A had a moderate
clinical outcome ofE. colimastitis, based on their QMP
of the noninfected quarters on d +2 p.i.Milk production
in the noninfected quarters returned to preinfection
level on d +2 p.i. (Figure 1). Rectal temperature in-
creased from PIH 9 onwards, with peak fever reached
at PIH 12 (Figure 2a). Heart rate and RR peaked at
PIH 12 (Figures 2b and 2c). Rumen motility was de-
pressed from PIH 9 onwards, resulting in a decrease
in appetite. Primiparous cows returned to normal ap-
petite and reticulorumen motility around PIH 21. Ud-
der parameters, such as swelling and elevated quarter
temperature, appeared at PIH 9 in the infected quar-
ters. Teat relaxation, milk leakage, and diarrhea, con-
sidered as indicators for severe clinical illness, only
appeared in a small number of animals. Changes to
abnormal milk with clots, flakes, and a watery appear-
ance were maximally present in all infected animals
at PIH 18 (results not shown). Body condition score
slightly decreased from 3.5 to 2.5 between calving and
the end of the experimental challenge period.
Based on the severity scoring adapted from Wenz et
al. (2001), primiparous cows in group A predominantly
reacted with a mild response (n = 7) at PIH 9. At
PIH 12, the clinical symptoms progressed mostly to a
moderate response (n = 7). Thereafter, only one heifer
with a moderate response was observed at PIH 15.
No severe responses were observed at any timepoint
between PIH 9 and 48 in group A, which received the
1 × 104 cfu E. coli inoculum dose.
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Figure 2. Rectal temperature (a), heart rate (b), respiration rate (c), left quarter milk production (d), number of colony-forming units of
E. coli P4:O32 (e), SCC (f), percentage of myelocytes-metamyelocytes (g), percentage of band cells (h), percentage of mature neutrophils (i),
blood leukocyte count (j), lactose (k), serum albumin (l), milk sodium (m), milk chlorine (n), and milk potassium (o) from postinfusion h −96
until postinfusion h 72 in infected quarters or blood, respectively, from primiparous cows infused with 1 × 104 (—; group A; n = 9) and 1 ×
106 (------; group B; n = 10) cfu of Escherichia coli P4:O32. Data are means.
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Milk production in the infected quarters maximally
decreased (±55%) on the day of challenge. At d +1 p.i.,
MP gradually increased and almost totally recovered
by d +3 p.i (Figure 2d). The number of E. coli in the
infected quarters peaked at PIH 6, followed by a rapid
clearance until PIH 15. At PIH 72, only 5 animals still
had low numbers of E. coli in the infected quarters
(Figure 2e). Somatic cell count rapidly increased from
PIH 6, reached a maximum at PIH 12, and remained
high until the end of the experiment at PIH 72 (Fig-
ure 2f).
Blood leukocyte count decreased to nadir at PIH 12
and recovered to preinfection level at PIH 48 (Figure
2j). The presence of early immature PMN (myelocytes-
metamyelocytes) in circulation increased at PIH 6 and
reached peak levels at PIH 21 (Figure 2g). Similarly,
maximal percentages of late immature PMN (band
cells) were reached at PIH 21 (Figure 2h). Concomi-
tantly, circulating mature PMN decreased at PIH 6
with nadir at PIH 12 (Figure 2i).
The concentration of lactose in the infected quarters
decreased from PIH 9 with a minimum at PIH 21 to
24 (Figure 2k). Serum albumin in the infected quarters
increased from PIH 9 and peaked at PIH 15 (Figure
2l). Sodium and chloride concentrations peaked at PIH
12 (Figures 2m and 2n), whereas potassium concentra-
tion decreased from PIH 9 and reached its greatest
reduction at PIH 12 (Figure 2o). All indicators for the
disintegration of the blood-milk barrier gradually re-
covered to preinfection levels at PIH 72, after reaching
their peak values (Figures 2k to 2o).
Clinical and Laboratory Results of Primiparous
Cows in Group B Inoculated with 1 × 106 cfu
Clinical reaction and changes in laboratory parame-
terswere similar to the previously described results for
group A. However, the changes during inflammation
generally appeared more rapidly (approximately 3 h)
in primiparous cows from group B, which were infused
with the 1 × 106 cfu E. coli inoculum dose, compared
with group A, which were infused with the 1 × 104 cfu
E. coli inoculum dose.
All primiparous cows in this group reacted with a
moderate clinical response to intramammary E. coli
infusion. Milk production in the noninfected quarters
was only decreased until d +1 p.i. (Figure 1). Rectal
temperature increased from PIH 6, peaked at PIH 9,
and gradually decreased to preinfection values at PIH
18 (Figure 2a). Peak tachycardia was reached at PIH
9 (Figure 2b), whereas maximal RR was reached at
PIH 12 (Figure 2c). Reticulorumen motility and all
other clinical parameters seemed to change some 3 h
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earlier in group B. The same trend in BCS could be
observed as in group A.
Clinical scores, adapted from Wenz et al. (2001),
showed an earlier reaction (approximately 3 h) in
group B compared with group A. At PIH 9, most of the
primiparous cows reacted moderately (n = 8), gradu-
ally decreasing at PIH 12 (n = 5). Only one animal in
group B had a prolonged moderate response until PIH
24. No severe responses were present in this group at
any timepoint between PIH 9 and 48.
Milk production reduction in the infected quarters
was maximal (±65%) on the day of infusion and recov-
ered rapidly to preinfection production at d +3 p.i.
(Figure 2d). The number of E. coli in the infected quar-
ters peaked at PIH 3 (Figure 2e). A rapid influx of cells
into the infected quarters was observed from PIH 3,
with a peak at PIH 9 (Figure 5f).
The number of circulating blood leukocytes de-
creased from PIH 6, peaking at PIH 9. A pronounced
rebound effect was observed between PIH 15 and 48
(Figure 2j). The increase in circulating early immature
cells was pronounced and peaked at PIH 15 (Figure
2g). Band cells increased at PIH 9 and peaked at PIH
18, thereafter gradually decreasing to reach prechal-
lenge levels at PIH 72 (Figure 2h). The greatest reduc-
tion in circulating mature PMN was reached at PIH
3, gradually increasing to preinfection values at PIH
21 (Figure 2i).
The concentrations of lactose, serum albumin, so-
dium, chloride, and potassium followed similar kinet-
ics as in group A, although the initial changes ap-
peared approximately 3 h earlier (Figure 2k to o).
DISCUSSION
In this study, the same strain and range of high
inoculum dose of E. coli was used to induce E. coli
mastitis as previously described (Heyneman et al.,
1990; Vandeputte-Van Messom et al., 1993; Hoeben et
al., 2000; Dosogne et al., 2002). In contrast to previous
studies, primiparous cows were used. Similar clinical
symptoms, such as quarter inflammation, fever, de-
pression of reticuloruminal motility, loss of appetite,
and general discomfort were observed as expected. In
previous studies, however, the clinical responses
showed large variations frommild-moderate to severe,
whereas in the present study, the variation in clinical
response was quite narrow. Quarter inflammation was
associated with a temporary loss of MP, combined with
the secretion of abnormal milk from the infected
glands. Maximal decrease in MP in the infected and
noninfected quarters occurred on the day of challenge,
in contrast to previous observations where maximal
decrease in MP was observed later (Heyneman et al.,
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Figure 3. Percentage of initial quarter milk production (MP) in
the uninfected quarters on d +2 (postinfusion h 48 to 72) relative to
infection. A. Primiparous cows infused with 1 × 104 (group A; n = 9)
or 1 × 106 (group B; n = 10) cfu of Escherichia coli P4:O32 in both
left quarters (present study). B. Multiparous cows infused with 1 ×
103 cfu of Escherichia coli O157 in both left quarters and scored into
moderate (n = 7) and severe (n = 5) clinical response (Dosogne et
al., 1997; historical control). Means (•) and standard deviation (I) of
percentages of initial MP in the uninfected quarters were given for
each group. Line (....) at 50% of initial MP arbitrarily indicates the
difference between moderate and severe responders (Vandeputte-
Van Messom et al., 1993).
1990; Hoeben et al., 2000). In the present study, none
of the animals reacted severely following intramam-
mary E. coli challenge (Figure 3). In both infected and
noninfected quarters, milk production seemed to re-
cover more rapidly on d +1 p.i. in primiparous cows
from group B, which received the 1 × 106 cfu E. coli
inoculum dose. Animals were scored as previously de-
scribed (Vandeputte-Van Messom et al., 1993) and
compared with the clinical score used by Wenz et al.
(2001). This resulted in a similar classification of mild
and moderate responses. The only difference that
could be observed between group A and group B was
that the time of latencywas shorterwhen higher inocu-
lum doses were used.
Body condition score and the concentration of BHBA
and glucose indicated that the primiparous cows in
this study were not ketotic at the time of challenge
(Kremer et al., 1993b), although their QMP was com-
parable to the multiparous cows previously challenged
(Heyneman et al., 1990; Vandeputte-Van Messom et
al., 1993).
The number of circulating PMN, a marker to predict
the clinical outcome of the disease, was similar to the
levels previously observed in moderate responders
(Vandeputte-Van Messom et al., 1993). Primiparous
cows in this study could therefore be expected to react
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with a moderate clinical response. Although no PMN
functionality was determined in this study, it is ex-
pected that PMN ROS production was high in these
primiparous cows. Mehrzad et al. (2002) recently
found that in the period from 5 wk before until 5 wk
postparturition the chemiluminescence activity of
PMNwas higher in primiparous cows than in multipa-
rous cows. Production of PMN ROS and chemotactic
activity were inversely correlated to the clinical out-
come of E. coli mastitis (Heyneman et al., 1990;
Kremer et al., 1993a, 1993b). No significant relation-
ship with the reduction in MP on d +2 p.i. was ob-
served. This is possibly due to the limited number of
animals in this study.
The onset of local clinical signs of mastitis, charac-
terized by quarter swelling, coincided with the influx
of PMN to the infected quarters. Somatic cell count
increased rapidly in both groups, which is in accor-
dance with earlier observations, where moderate re-
sponders had a rapidly occurring leucocytosis in the
infected glands (Vandeputte-VanMessom et al., 1993).
The extraction of mature PMN from the blood to the
infected glands is known to result in early and late
immature PMN recruitment from the bone marrow to
restore the number of circulating PMN. In this study
the recruitment of immature PMN was of short dura-
tion, when compared with Heyneman et al. (1990),
who observed immature forms in circulation for at
least 3 d in moderate responders and for almost 10 d
in severe responders.
The rapid influx of PMN into the infected glands
was associated with fast clearance of bacteria from the
quarters. In this study, high inoculum doses were used
for experimental induction of E. coli mastitis because
we were mainly interested in bacterial clearance,
rather than bacterial growth in the mammary gland.
In contrast to an earlier study with the same inoculum
dose in multiparous animals (Vandeputte-Van Mes-
som et al., 1993), peak bacterial numbers were already
reached around PIH 3 to 6. This peak number of bacte-
ria was followed by a rapid clearance from the affected
glands. Contrary to the induction of E. coli mastitis
with low inoculum doses, where clearance is preceded
by excessive bacterial growth, in this study, peak num-
bers were reached within 6 h p.i. and followed by a
subsequent bacterial clearance. Therefore, PMN influx
is thought to be fast and strong enough to rapidly
clear the bacteria from the affected glands. It can be
presumed that the bactericidal capacity of the PMN
migrated to the infected quarters is high because more
efficient PMN functionality was reported in primipa-
rous cows recently (Mehrzad et al., 2002).
Several indicators (lactose, serum albumin, sodium,
chloride, and potassium) for the disintegration of the
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blood-milk barrier were determined in this study. Gen-
erally, the changes could be observed approximately
3 h earlier in group B. Peak levels were almost identi-
cal for both groups, however, which coincides with all
other data, indicating that the animals reacted with
a mild to moderate response and that little variation
in the clinical response was present in this study.
From this study, it appears that the inflammatory
response in primiparous cows from group B has an
earlier onset compared with group A. One possible
explanation for this observation could be the 100-fold
difference in the number of E. coli infused into the
mammary glands because the amount of LPS produced
is related to the number ofE. coli bacteria (Burvenich.,
1983; Cross et al., 1993; Monfardini et al., 1999). A
direct effect of LPS present in the inoculum can be
excluded because the bacterial cultures were washed
3 times in pyrogen-free PBS before further dilutions
were made. Lipopolysaccharide, known as a potent
inducer of inflammatory cytokines (Shuster et al.,
1993), can be produced quite rapidly during bacterial
growth following intramammary infusion. Therefore,
a sufficient amount of inflammatory cytokines should
be produced early during inflammation in both groups,
resulting in the rapid attraction of PMN from the blood
into the mammary gland, with a subsequent pro-
nounced increase of SCC in the infected glands.
Following E. colimastitis, treatment with a bacteri-
cidal antibiotic at PIH 10 has been shown to be ineffi-
cient to alter local and systemic symptoms already
present, although the number of bacteria in the in-
fected quarters decreased 100-fold (Monfardini et al.,
1999). Therefore, it can be suggested that early in-
flammatory events (first 3 h) could play an important
role in the further regulation of the inflammatory re-
sponse to combat the invading organisms. Experimen-
tal design in this study, particularly in relation to the
number and time of samplings, however, was not suit-
able for unraveling these elements of early acute
phase response.
CONCLUSIONS
In conclusion, despite the use of relative high inocu-
lum doses, primiparous cows react with a moderate
inflammatory response following intramammary infu-
sion. This moderate response was evident from the
preinfection number of circulating leukocytes, the con-
centration of BHBA and glucose, the prompt clinical
response, the rapid influx of PMN into the infected
quarters, the efficient bacterial clearance of the af-
fected glands, and the fast recovery of MP in both
infected and noninfected glands. To follow-up the bac-
terial clearance from the affected glands, the use of
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a high inoculum dose was of particular interest. In
contrast to previous studies, preinfection parameters
were not significantly related to the clinical outcome
of the disease in terms of severity. The absence of a
significant relation between these parameters could
be due to the narrow variation in clinical response in
the present study, especially compared with the large
variation, ranging from mild-moderate to severe, ob-
served in previous studies. The difference in time of
latency between both inoculum doses could also be
considered as an interesting observation. However, to
further elucidate the effect of inoculum dose, a com-
pletely randomized study should be designed for this
purpose.
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